These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Fibroblast Growth Factor 23 Level and Cardiovascular Parameters in Children with Chronic Kidney Disease. Singh G, Mishra OP, Abhinay A, Agarwal V, Mishra SP, Dwivedi AD, Singh A, Prasad R, Mishra RN. Indian J Pediatr; 2022 Sep; 89(9):865-871. PubMed ID: 34767187 [Abstract] [Full Text] [Related]
27. Active vitamin D is cardioprotective in experimental uraemia but not in children with CKD Stages 3-5. Schön A, Leifheit-Nestler M, Deppe J, Fischer DC, Bayazit AK, Obrycki L, Canpolat N, Bulut IK, Azukaitis K, Yilmaz A, Mir S, Yalcinkaya F, Soylemezoglu O, Melk A, Stangl GI, Behnisch R, Shroff R, Bacchetta J, Querfeld U, Schaefer F, Haffner D, 4C and Study Consortium and the ESPN CKD-MBD Working Group. Nephrol Dial Transplant; 2021 Feb 20; 36(3):442-451. PubMed ID: 33241290 [Abstract] [Full Text] [Related]
28. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL. Nephrol Dial Transplant; 2013 Feb 20; 28(2):352-9. PubMed ID: 23129826 [Abstract] [Full Text] [Related]
29. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease . Yin C, Cheng C, Wang J, Zhang L, Purrunsing Y, Yang G, Zeng M, Huang H, Ren W, Ye Y, Ma H, Xing C, Wang N. Clin Nephrol; 2020 Feb 20; 93(2):65-76. PubMed ID: 31793871 [Abstract] [Full Text] [Related]
30. Association of pulse pressure, pulse pressure index, and ambulatory arterial stiffness index with kidney function in a cross-sectional pediatric chronic kidney disease cohort from the CKiD study. Raina R, Polaconda S, Nair N, Chakraborty R, Sethi S, Krishnappa V, Kapur G, Mhanna M, Kusumi K. J Clin Hypertens (Greenwich); 2020 Jun 20; 22(6):1059-1069. PubMed ID: 32472978 [Abstract] [Full Text] [Related]
35. Association of klotho gene polymorphism and the regulation of calcium-phosphate metabolism disorders in patients with end-stage renal disease. Zeng QY, Xia ZY, Tong YS, Sun L, Mou HB, Chen R, Bi GY, Liu CH. Nephrology (Carlton); 2019 Oct 20; 24(10):1001-1008. PubMed ID: 30537427 [Abstract] [Full Text] [Related]
37. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study. Kim ED, Sozio SM, Estrella MM, Jaar BG, Shafi T, Meoni LA, Kao WH, Lima JA, Parekh RS. BMC Nephrol; 2015 Aug 07; 16():131. PubMed ID: 26249016 [Abstract] [Full Text] [Related]
38. Association between circulating fibroblast growth factor 23, α-Klotho, and the left ventricular ejection fraction and left ventricular mass in cardiology inpatients. Shibata K, Fujita S, Morita H, Okamoto Y, Sohmiya K, Hoshiga M, Ishizaka N. PLoS One; 2013 Aug 07; 8(9):e73184. PubMed ID: 24039882 [Abstract] [Full Text] [Related]
40. Vitamin D deficiency is associated with increased left ventricular mass and diastolic dysfunction in children with chronic kidney disease. Patange AR, Valentini RP, Gothe MP, Du W, Pettersen MD. Pediatr Cardiol; 2013 Mar 07; 34(3):536-42. PubMed ID: 22941497 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]